Bulut Gökten, D. and Mercan, R. (2026) “Clinical Outcomes after Switching from Originator Infliximab to the Biosimilar Ixifi in Patients with Axial Spondyloarthritis: A Single-Center Study from Türkiye”, Rheumatology (Bulgaria), 34(1), pp. 4–20. doi:10.35465/wx09tq86.